Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/1998
12/03/1998WO1998054158A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56lck TYROSINE KINASES
12/03/1998WO1998054157A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p561ck TYROSINE KINASES
12/03/1998WO1998054156A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR P56lck TYROSINE KINASES
12/03/1998WO1998054152A1 Azacyclooctane and heptane derivatives, their preparation and usein therapy
12/03/1998WO1998054149A1 Process for obtaining quinapryl hydrochloride and solvates useful for isolating and purifying quinapryl hydrochloride
12/03/1998WO1998054147A1 Cyanoamidines as cell proliferation inhibitors
12/03/1998WO1998054145A1 Cyanoguanidines as cell proliferation inhibitors
12/03/1998WO1998054144A1 Cyanoguanidines as cell proliferation inhibitors
12/03/1998WO1998054143A1 Cyanoguanidines as cell proliferation inhibitors
12/03/1998WO1998054141A1 Cyanoguanidines as cell proliferation inhibitors
12/03/1998WO1998054138A1 Novel orally active iron (iii) chelators
12/03/1998WO1998054093A1 Novel angiogenesis inhibitors
12/03/1998WO1998053856A1 Methods for the detection, treatment, and prevention of neurodegeneration
12/03/1998WO1998053846A1 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
12/03/1998WO1998053845A1 Synthetic, statistic thymus peptide combination and its use as a preparation with immunological and/or endocrinological effect
12/03/1998WO1998053838A2 A soluble laminin receptor precursor and methods to inhibit its interactions
12/03/1998WO1998053834A1 Use of low-molecular-weight heparins for preventing and treating cerebral edemas
12/03/1998WO1998053824A1 Novel process
12/03/1998WO1998053821A1 USE OF 4-SUBSTITUTED TETRAHYDROPYRIDINES FOR MAKING MEDICINES ACTING ON TGF-β1
12/03/1998WO1998053818A1 Sulfonamides as cell adhesion inhibitors
12/03/1998WO1998053814A1 Heterocyclic amide compounds as cell adhesion inhibitors
12/03/1998WO1998042739A3 Secreted proteins and polynucleotides encoding them
12/03/1998WO1998037873A3 Method for reducing secretion of apolipoprotein b in animals by administering conjugated linoleic acid
12/03/1998DE19724187A1 11beta-Arylsubstituierte 14,17-Ethanoestratriene, Verfahren zur Herstellung dieser Verbindungen, sowie ihre Verwendung zur Herstellung von Arzneimitteln 11beta-aryl-substituted 14,17-ethanoestratrienes, processes for preparing these compounds, and their use for the preparation of medicaments
12/03/1998DE19719652A1 Use of tissue factor
12/03/1998CA2292877A1 Cyanoguanidines as cell proliferation inhibitors
12/03/1998CA2292790A1 Human tumor necrosis factor receptor tr10
12/03/1998CA2291960A1 Human type 3 ryanodine receptor protein and dna molecules coding therefor
12/03/1998CA2291861A1 Zinc finger protein derivatives and methods therefor
12/03/1998CA2291778A1 Heterocyclic amide compounds as cell adhesion inhibitors
12/03/1998CA2291774A1 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
12/03/1998CA2291750A1 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
12/03/1998CA2291728A1 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
12/03/1998CA2291720A1 Pharmaceutical compositions comprising a soluble laminin receptor precursor of a compound which blocks the interaction of the laminin receptor precursor and prpsc or prpc
12/03/1998CA2291709A1 Novel angiogenesis inhibitors
12/03/1998CA2291708A1 Sulfonamides as cell adhesion inhibitors
12/03/1998CA2291595A1 Dna methyltransferase genomic sequences and antisense oligonucleotides
12/03/1998CA2291489A1 Cyanoguanidines as cell proliferation inhibitors
12/03/1998CA2291451A1 Inhibition of stress activated protein kinase (sapk) pathway and sensitization of cells to cancer therapies
12/03/1998CA2291251A1 Novel process
12/03/1998CA2291235A1 Cyanoamidines as cell proliferation inhibitors
12/03/1998CA2291086A1 Sulfate salt of an hiv protease inhibitor having an improved oral absorption and bioavailability
12/03/1998CA2290954A1 Human multiple endocrine neoplasia type 1 protein
12/03/1998CA2290682A1 Use of low-molecular-weight heparins for preventing and treating cerebral edemas
12/03/1998CA2290070A1 Salts of aromatic sulphonic acids
12/03/1998CA2289576A1 Azacyclooctane and heptane derivatives, their preparation and use in therapy
12/03/1998CA2289037A1 Spiro-azacyclic derivatives and their use as therapeutic agents
12/03/1998CA2288967A1 Selective induction of cell death by delivery of amino-terminal interleukin-1-alpha pro-piece polypeptide
12/03/1998CA2288810A1 Ergoline derivatives and their use as somatostatin receptor antagonists
12/03/1998CA2288317A1 2-amino-7-(1-substituted-2-hydroxyethyl)-3,5-dihydro-pyrrolo¬3,2-d|pyrimidin-4-ones
12/02/1998EP0881298A2 Metalloporoteases
12/02/1998EP0881296A2 Histidine kinase
12/02/1998EP0881294A2 HOEFCC11, a HAS2 splicing variant
12/02/1998EP0881289A2 Novel 7TM receptor (H2CAA71)
12/02/1998EP0881285A1 D-Alanine transferase
12/02/1998EP0881219A1 N-substituted dioxothiazolidylbenzamide derivatives and process for producing the same
12/02/1998EP0880597A1 THERAPEUTIC APPLICATIONS FOR THE ANTI-T-BAM (CD40-L) MONOCLONAL ANTIBODY 5c8
12/02/1998EP0880584A1 Cytokine expressed by dia/lif-deficient embryonic stem cells for the inhibition of differentiation
12/02/1998EP0880558A1 Combinatorial process for preparing substituted indane libraries
12/02/1998EP0880542A2 Substrates and inhibitors for cysteine protease ich-1
12/02/1998EP0880540A1 17-beta-cyclopropyl(amino/oxy) 4-aza steroids as active inhibitors of testosterone 5-alpha-reductase and c17-20-lyase
12/02/1998EP0880529A1 Spiro-ketal derivatives and their use as therapeutic agents
12/02/1998EP0880528A1 Spiro-ketal derivatives and their use as therapeutic agents
12/02/1998EP0880526A1 Heterocycle-condensed morphinoid derivatives (ii)
12/02/1998EP0880524A1 New triazolopurines, method of preparing them and their use as drugs
12/02/1998EP0880523A1 Pyrazolopyrimidines as crf receptor antagonists
12/02/1998EP0880522A1 5H,10H-IMIDAZO 1,2-a]INDENO 1,2-e]PYRAZINE-4-ONE DERIVATIVES, PREPARATION THEREOF, INTERMEDIATES THEREOF AND DRUGS CONTAINING SAME
12/02/1998EP0880519A1 Thiazolylbenzofuran derivatives and pharmaceutical compositions containing them
12/02/1998EP0880517A1 Quinazoline compounds
12/02/1998EP0880511A1 Integrin receptor antagonists
12/02/1998EP0880501A1 Heterocyclic compounds useful as pharmaceutical agents
12/02/1998EP0771210A4 TWO NON-CONTIGUOUS REGIONS CONTRIBUTE TO NIDOGEN BINDING TO A SINGLE EGF-LIKE MOTIF OF THE LAMININ -g(g)1 CHAIN
12/02/1998EP0746564B1 4-n-substituted sialic acids and their sialosides
12/02/1998EP0583358B1 Partial liquid breathing of fluorocarbons
12/02/1998EP0544779B1 Heterocyclic compounds and their preparation and use
12/02/1998CN1200732A Farnesyl transferase inhibiting 2-quinolone derivatives
12/02/1998CN1200673A Eye drops
12/02/1998CN1200670A Pharmaceutical compositions contg. hydroximic acid derivatives
12/02/1998CN1200374A Vitronectin receptor antagonists, their prepn. and their use
12/02/1998CN1200373A Vitronectin receptor antagonists, their prepn. and use
12/02/1998CN1200294A Medicine for treating hernia
12/02/1998CN1200286A Compound traditional Chinese medicine for treating lung diseases, and method for preparing same
12/02/1998CN1040985C Method for prepn. of benzo-aza-tropilidene compound
12/02/1998CN1040945C Process for preparing chloroformyl diphosphate
12/02/1998CA2238580A1 Cell adhesion inhibitors
12/02/1998CA2230963A1 A human 7-tm receptor similar to murine frizzled-6 gene
12/01/1998US5844099 Cytokine antagonists
12/01/1998US5844084 Chemokine expressed in inflamed adenoid
12/01/1998US5844079 Vertebrate embryonic pattern-inducing proteins, and uses related thereto
12/01/1998US5844078 Phenyl peptides, method for preparing same, and pharmaceutical compositions containing said peptides
12/01/1998US5844004 10-substituted 1,8-dihydroxy-9 (10H) anthracenone pharmaceuticals
12/01/1998US5843996 Intravenous magnesium gluconate for treatment of conditions caused by excessive oxidative stress due to free radical distribution
12/01/1998US5843994 Compositions and methods for treating and preventing pathologies including cancer
12/01/1998US5843988 Cyclopropachromencarboxylic acid derivatives
12/01/1998US5843986 Tricyclic amide compounds
12/01/1998US5843980 Benzamidoxime prodrugs as antipneumocystic agents
12/01/1998US5843972 Heterocyclic β-adrenergic agonists
12/01/1998US5843968 Symmetrical bis-heteroarylmethoxy-phenylalkyl carboxylates as inhibitors of leukotriene biosynthesis
12/01/1998US5843966 Piperidine derivatives
12/01/1998US5843965 Benzo B! thiophene compounds, intermediates, processes, compositions, and methods
1 ... 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 ... 1564